PTEN down regulates AP-1 and targets c-fos in human glioma cells Via PI3-kinase/Akt pathway (original) (raw)

• Walker MD, Alexander E, Hunt WE (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: A cooperative clinical trial. J Neurosurg 49:333–343
  Article PubMed CAS Google Scholar
• Walker MD, Green SB, Byar DP (1980) TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. N Engl J Med 303:1323–1329
  Article PubMed CAS Google Scholar
• Davis FG, McCarthy BJ, Freels S (1999) The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data. Cancer 85:485–491
  Article PubMed CAS Google Scholar
• Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:4240–4245
  Article PubMed CAS Google Scholar
• Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29–39
  Article PubMed CAS Google Scholar
• Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK (1998) The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc Natl Acad Sci USA 95:13513–13518
  Article PubMed CAS Google Scholar
• Vazquez F, Sellers WR (2000) The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim Biophys Acta 1470:M21–M35
  PubMed CAS Google Scholar
• Leevers SJ, Vanhaesebroeck B, Waterfield MD (1999) Signaling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol 11:219–225
  Article PubMed CAS Google Scholar
• Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231–241
  Article PubMed CAS Google Scholar
• Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC (1997) Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318–1321
  Article Google Scholar
• Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–868
  Article PubMed CAS Google Scholar
• Romashkova JA, Makarov SS (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401:86–89
  Article PubMed CAS Google Scholar
• Reddy SAG, Huang JH, Liao L (2000) Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation. J Immunol 164:1355–1363
  PubMed CAS Google Scholar
• Koul D, Yao Y, Abbruzzese JL, Yung WK, Reddy SA (2001) Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFkappaB activation without interfering with the IkappaB degradation pathway. J Biol Chem 276:11402–11408
  Article PubMed CAS Google Scholar
• Karin M, Liu Z, Zandi E (1997) AP-1 function and regulation. Curr Opin Cell Biol 9:240–246
  Article PubMed CAS Google Scholar
• Curran T, Franza BR Jr (1988) Fos and Jun: the AP-1 connection. Cell 55:395–397
  Article PubMed CAS Google Scholar
• Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3:859–868
  Article PubMed CAS Google Scholar
• Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, Yuspa SH, Spiegelman BM (1995) c-fos is required for malignant progression of skin tumors. Cell 82:721–732
  Article PubMed CAS Google Scholar
• Malliri AM, Symons RF, Hennigan AF, Hurlstone RF, Lamb T, Wheeler BW (1998) The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells. J Cell Biol 143:1087–1099
  Article PubMed CAS Google Scholar
• Belguise KN, Kersual F, Galtier D (2005) FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 24:1434–1444
  Article PubMed CAS Google Scholar
• Kustikova O, Kramerov D, Grigorian M, Berezin V, Bock E, Lukanidin E, Tulchinsky E (1998) Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol Cell Biol 18:7095–7105
  PubMed CAS Google Scholar
• Angel P, Karin M (1991) The role of Jun, Fos, the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072:129–157
  PubMed CAS Google Scholar
• Jochum W, Passegué E, Wagner EF (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20:2401–2412
  Article PubMed CAS Google Scholar
• Shaulian E, Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20:2390–2400
  Article PubMed CAS Google Scholar
• Huang C, Schmid PC, Ma WY, Schmid HH, Dong Z (1997) Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein 1 activation. J Biol Chem 272:4187–4194
  Article PubMed CAS Google Scholar
• Koul D, Jasser SA, Lu Y, Davies MA, Shen R, Shi Y, Mills GB, Yung WK (2002) Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity. Oncogene 15:2357–2364
  Article Google Scholar
• Reddy SAG, Huang JH, Liao WSL (1997) Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation. J Biol Chem 272:29167–29172
  Article PubMed CAS Google Scholar
• Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21:99–102
  Article PubMed CAS Google Scholar
• Gopalan SM, Wilczynska KM, Konik BS, Bryan L, Kordula T (2006) Astrocyte-specific expression of the alpha1-antichymotrypsin and glial fibrillary acidic protein genes requires activator protein-1. J Biol Chem 281:1956–1963
  Article PubMed CAS Google Scholar
• Sizemore N, Leung S, Stark GR (1999) Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol 19:4798–4805
  PubMed CAS Google Scholar
• Huang C, Ma WY, Dong Z (1996) Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells. Mol Cell Biol 16:6427–6435
  PubMed CAS Google Scholar
• Van Leeuwen JE, Paik PK, Samelson LE (1999) Activation of nuclear factor of activated T cells-(NFAT) and activating protein 1 (AP-1) by oncogenic 70Z Cbl requires an intact phosphotyrosine binding domain but not Crk(L) or p85 phosphatidylinositol 3-kinase association. J Biol Chem 274:5153–5162
  Article PubMed Google Scholar
• Fahy BN, Schlieman M, Virudachalam S, Bold RJ (2003) AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2. Br J Cancer 89:391–397
  Article PubMed CAS Google Scholar
• Shah SA, Potter MW, Hedeshian MH, Kim RD, Chari RS, Callery MP (2001) PI-3′ kinase and NF kappaB cross-signaling in human pancreatic cancer cells. J Gastrointest Surg 5:603–612
  Article PubMed CAS Google Scholar
• Hu Q, Klippel A, Muslin AJ, Fantl WJ, Williams LT (1995) Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268:100–102
  Article PubMed CAS Google Scholar
• Barber JR, Verma IM (1987) Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum. Mol Cell Biol 7:2201–2211
  PubMed CAS Google Scholar
• Holt JT, Gopal TV, Moulton AD, Nienhuis AW (1986) Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc Natl Acad Sci USA 83:4794–4798
  Article PubMed CAS Google Scholar
• Piechaczyk M, Blanchard JM (1994) c-fos proto-oncogene regulation and function. Crit Rev Oncol Hematol 17:93–131
  PubMed CAS Google Scholar
• Bland KI, Konstadoulakis MM, Vezeridis MP, Wanebo HJ (1995) Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg 221:706–718
  Article PubMed CAS Google Scholar
• Arteaga CL, Holt JT (1996) Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice. Cancer Res 56:1098–1103
  PubMed CAS Google Scholar
• Gee JM, Ellis IO, Robertson JF, Willsher P, McClelland RA, Hewitt KN, Blamey RW, Nicholson RI (1995) Immunocytochemical localization of Fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int J Cancer 22:269–273
  Article Google Scholar
• Preston GA, Lyon TT, Yin Y, Lang JE, Solomon G, Annab L, Srinivasan DG, Alcorta DA, Barrett JC (1996) Induction of apoptosis by c-Fos protein. Mol Cell Biol 16:211–218
  PubMed CAS Google Scholar
• Gajate C, Alonso MT, Schimmang T, Mollinedo F (1996) C-Fos is not essential for apoptosis. Biochem Biophys Res Commun 21:267–272
  Article Google Scholar
• Roffler-Tarlov S, Brown JJ, Tarlov E, Stolarov J, Chapman DL, Alexiou M, Papaioannou VE (1996) Programmed cell death in the absence of c-Fos and c-Jun. Development 122:1–9
  PubMed CAS Google Scholar